MH
Masashi Hasebe
Research areas: Medicine · Endocrinology, Diabetes and Metabolism · Diabetes Treatment and Management · Heart Failure Treatment and Management · Genetic Associations and Epidemiology
0000-0001-7031-2446
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (41)
- Cardiovascular Effects of GLP‐1 Receptor Agonists Across Age Groups: An Updated Meta‐Analysis of Randomized Controlled Trials Save
- Combination therapy with mineralocorticoid receptor antagonists and SGLT2 inhibitors in chronic kidney disease: an updated meta-analysis Save
- Cardiovascular Efficacy of GLP‐1 Receptor Agonists by Kidney Function: An Updated Meta‐Analysis of Randomized Trials Including the SOUL Trial Save
- Genomic atlas of cardiac and adiposity imaging phenotypes Save
- Type 2 Diabetes Partitioned Polygenic Scores Are Differentially Associated with Aging Hallmarks Save
- Estimated Glomerular Filtration Rate Change and Heart Failure Events With GLP‐1 Receptor Agonists: A Meta‐Analysis and Meta‐Regression of Randomised Controlled Trials Save
- Population-Scale, Genotype-First Characterization of Monogenic Diabetes in 374,973 Multi-Ancestry Individuals from the All of Us Research Program Save
- Monogenic diabetes in Japan and India: A call for broader screening Save
- Systematic variant-to-gene mapping highlights TGFB2 and VEGFA as adipokine-coding genes with non-obese, insulin-resistance-like characteristics and distinct disease risks Save
- GLP‐1 receptor agonists and cardiovascular outcomes in Asian, Black or African American, and White populations: An updated meta‐analysis including the SOUL trial Save
- Comment on Sun et al. SGLT2i Versus Metformin for Delirium Prevention in Type 2 Diabetes: A Real-World, Head-to-Head Comparative Study. Diabetes Care 2025;48:1361–1369 Save
- Clinical and Genetic Characteristics of Monogenic Diabetes: A Report from the Japan Diabetes Society Committee,単一遺伝子異常による糖尿病の成因，診断，治療に関する委員会報告 Save
- Integrative plasma proteomic network analysis identifies physical activity-associated protein modules potentially mediating type 2 diabetes risk Save
- Proteome-wide Mendelian randomization implicates TIMP2 as a putative causal protein for bone mineral density and fracture risk Save
- Cardiovascular risk reduction with glucagon‐like peptide‐1 receptor agonists is proportional to HbA1c lowering in type 2 diabetes: An updated meta‐regression analysis incorporating FLOW and SOUL trials Save
- Multi-ancestry proteogenomic analysis identifies risk proteins for intracranial aneurysms Save
- Comment on Kofod et al. The Association Between Hemoglobin A1c and Complications Among Individuals With Diabetes and Severe Chronic Kidney Disease. Diabetes Care 2025;48:1400–1409 Save
- Disentangling osteoarthritis-specific genetic effects from obesity to identify novel therapeutic targets Save
- Interpreting stroke risk after adverse pregnancy outcomes: methodological considerations for sibling analyses and long-term follow-up Save
- Comment on Dieguez et al. In Utero Exposure to Maternal Hyperglycemia and Offspring Type 2 Diabetes Genetic Risk Score Are Independently Associated With Risk of Impaired Glucose Tolerance in Youth. Diabetes Care 2025;48:1356–1360 Save